Related Experiment Video

Updated: Oct 9, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
00:07

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Complete inhibition of in vivo glioma growth by oncostatin M

M Friedrich1, N Höss, F Stögbauer

  • 1Department of Neurology, University of Münster, Münster, Germany.

Journal of Neurochemistry
|March 10, 2001
PubMed

Insights

Oncostatin M (OSM) inhibits glioblastoma tumor formation in mice. Inducing OSM expression in glioblastoma cells prevented tumor development, suggesting therapeutic potential for this cytokine.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Glioblastoma is an aggressive brain tumor with limited treatment options.
  • The role of oncostatin M (OSM) in glioblastoma tumorigenesis requires further investigation.

Purpose of the Study:

  • To investigate the in vivo effect of Oncostatin M (OSM) on glioblastoma tumor formation.
  • To explore the potential of OSM as a therapeutic agent for glioblastoma.

Main Methods:

  • Human glioblastoma cells were engineered to express OSM under a tetracycline-inducible promoter.
  • Cells were intracerebrally inoculated into nude mice.
  • Tumorigenesis was assessed in mice with and without induced OSM expression.

Main Results:

  • OSM induction led to differentiated glioblastoma cell morphology and inhibited proliferation.
  • Mice with induced OSM expression showed no tumor formation.
  • Mice lacking OSM expression developed large tumors.

Conclusions:

  • Oncostatin M (OSM) demonstrates significant antitumorigenic effects against glioblastoma in vivo.
  • OSM holds promise as a potential therapeutic strategy for treating glioblastoma.

More Related Videos

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...